Z

Zhejiang Xianju Pharmaceutical Co Ltd
SZSE:002332

Watchlist Manager
Zhejiang Xianju Pharmaceutical Co Ltd
SZSE:002332
Watchlist
Price: 12.6 CNY 0.08% Market Closed
Market Cap: 12.5B CNY
Have any thoughts about
Zhejiang Xianju Pharmaceutical Co Ltd?
Write Note

Zhejiang Xianju Pharmaceutical Co Ltd
Net Issuance of Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Zhejiang Xianju Pharmaceutical Co Ltd
Net Issuance of Debt Peer Comparison

Comparables:
H
3692
600436
600276
000538
S
688506

Competitive Net Issuance of Debt Analysis
Latest Figures & CAGR of Competitors

Company Net Issuance of Debt CAGR 3Y CAGR 5Y CAGR 10Y
Z
Zhejiang Xianju Pharmaceutical Co Ltd
SZSE:002332
Net Issuance of Debt
-ÂĄ141.9m
CAGR 3-Years
38%
CAGR 5-Years
9%
CAGR 10-Years
N/A
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Net Issuance of Debt
-ÂĄ19m
CAGR 3-Years
-36%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Net Issuance of Debt
ÂĄ163.2m
CAGR 3-Years
176%
CAGR 5-Years
5%
CAGR 10-Years
N/A
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Net Issuance of Debt
-ÂĄ10m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Yunnan Baiyao Group Co Ltd
SZSE:000538
Net Issuance of Debt
ÂĄ894.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Net Issuance of Debt
ÂĄ208m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Zhejiang Xianju Pharmaceutical Co Ltd's Net Issuance of Debt?
Net Issuance of Debt
-141.9m CNY

Based on the financial report for Jun 30, 2024, Zhejiang Xianju Pharmaceutical Co Ltd's Net Issuance of Debt amounts to -141.9m CNY.

What is Zhejiang Xianju Pharmaceutical Co Ltd's Net Issuance of Debt growth rate?
Net Issuance of Debt CAGR 5Y
9%

Over the last year, the Net Issuance of Debt growth was 42%. The average annual Net Issuance of Debt growth rates for Zhejiang Xianju Pharmaceutical Co Ltd have been 38% over the past three years , 9% over the past five years .

Back to Top